A hypothesis to phenotype COPD exacerbations by aetiology

COPD exacerbations have traditionally been defined on the basis of symptoms or health‐care utilization without specific reference to the suspected aetiology. Consequently, the term ‘exacerbation’ has been used to include all patients experiencing an acute deterioration of symptoms associated with COPD. However, exacerbations are known to result from a variety of causes and do not necessarily constitute an equivalent event in the same patient, between different patients or between individual research studies. We therefore hypothesize that phenotyping exacerbations by aetiology may identify exacerbation subgroups, clarify benefits of therapeutic intervention in the subgroups and overall improve clinical care. An acronym is proposed to facilitate phenotyping COPD exacerbations.

[1]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[2]  Edwin K Silverman,et al.  Chronic obstructive pulmonary disease phenotypes: the future of COPD. , 2010, American journal of respiratory and critical care medicine.

[3]  R. Pandey,et al.  Prevalence of viral infection detected by PCR and RT‐PCR in patients with acute exacerbation of COPD: A systematic review , 2010, Respirology.

[4]  T. Omachi,et al.  Influence of anxiety on health outcomes in COPD , 2010, Thorax.

[5]  W. Boersma,et al.  Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[6]  D. Caillaud,et al.  Clinical COPD phenotypes: a novel approach using principal component and cluster analyses , 2010, European Respiratory Journal.

[7]  M. Weatherall,et al.  Distinct clinical phenotypes of airways disease defined by cluster analysis , 2009, European Respiratory Journal.

[8]  M. Decramer,et al.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.

[9]  G. Donaldson,et al.  Relationship between depression and exacerbations in COPD , 2008, European Respiratory Journal.

[10]  Clifford W Colwell,et al.  Prevention of Venous Thromboembolism* American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition) , 2008 .

[11]  T. Murphy,et al.  Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[12]  J. Bourbeau,et al.  Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. , 2008, American journal of respiratory and critical care medicine.

[13]  B. Caldwell,et al.  External validity of randomized controlled trials in COPD. , 2007, Respiratory medicine.

[14]  B. Celli,et al.  Exacerbations of chronic obstructive pulmonary disease , 2007, European Respiratory Journal.

[15]  G. Donaldson,et al.  Inflammatory changes, recovery and recurrence at COPD exacerbation , 2007, European Respiratory Journal.

[16]  J. Wedzicha,et al.  What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines , 2007, Thorax.

[17]  Richard Beasley,et al.  External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? , 2006, Thorax.

[18]  J. Cornuz,et al.  Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease? , 2006, Thorax.

[19]  M. Christ-Crain,et al.  Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. , 2007, Chest.

[20]  J. Soriano,et al.  Dynamic hyperinflation and pulmonary inflammation: a potentially relevant relationship? , 2006, European Respiratory Review.

[21]  John R Hurst,et al.  Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[22]  T. Honda,et al.  Characteristics of COPD phenotypes classified according to the findings of HRCT. , 2006, Respiratory medicine.

[23]  S. Johnston,et al.  An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study , 2006, Respiratory research.

[24]  S. Johnston,et al.  Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. , 2006, American journal of respiratory and critical care medicine.

[25]  S. Sethi,et al.  Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[26]  C. Marquette,et al.  Pulmonary Embolism in Patients with Unexplained Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and Risk Factors , 2006, Annals of Internal Medicine.

[27]  C. Schindler,et al.  Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease. , 2006, American heart journal.

[28]  J. Wedzicha,et al.  Effect of Interactions Between Lower Airway Bacterial and Rhinoviral Infection in Exacerbations of COPD , 2006, Chest.

[29]  G. Donaldson,et al.  COPD exacerbations · 1: Epidemiology , 2006, Thorax.

[30]  S. Pallesen,et al.  Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. , 2005, Journal of psychosomatic research.

[31]  I. Pavord,et al.  Multi‐dimensional phenotyping: towards a new taxonomy for airway disease , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[32]  M. Martínez-García,et al.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease , 2005, Thorax.

[33]  C. Jenkins,et al.  The TORCH (TOwards a Revolution in COPD Health) survival study protocol , 2004, European Respiratory Journal.

[34]  Joan B Soriano,et al.  The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. , 2003, Chest.

[35]  J. Hollander,et al.  Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. , 2003, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[36]  A. Gillissen,et al.  Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study , 2003, Thorax.

[37]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[38]  D. Postma,et al.  Chronic obstructive pulmonary disease. , 2002, Clinical evidence.

[39]  E. Rönmark,et al.  The costs of exacerbations in chronic obstructive pulmonary disease (COPD). , 2002, Respiratory medicine.

[40]  S. Quintana,et al.  Mortality after hospitalization for COPD. , 2002, Chest.

[41]  F. Dekker,et al.  Risk of depression in patients with chronic obstructive pulmonary disease and its determinants , 2002, Thorax.

[42]  R. Wood‐Baker,et al.  Influenza vaccine for patients with chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.

[43]  R. Stockley,et al.  Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care , 2000, Thorax.

[44]  R. Stockley,et al.  Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. , 2000, Chest.

[45]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[46]  T. Seemungal,et al.  Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[47]  R. Rodríguez-Roisín,et al.  Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.

[48]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[49]  J. Schwartz,et al.  Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. , 1997, The European respiratory journal.

[50]  E. Vittinghoff,et al.  Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. , 1995, JAMA.